Sabra Health Care REIT Inc

Sabra Health Care REIT Inc(SBRA)股票分析

$19.290

+0.122 (+0.63%)收盤時

Loading chart…
最高
19.670
開盤
19.610
成交量加權均價
19.40
成交量
2.19M
市值
3.50B
最低
19.255
成交金額
42.44M
企業價值/稅息折舊攤銷前利潤(TTM)
88.80

Sabra Health Care REIT Inc operates as a self-administered, self-managed real estate investment trust that, through its subsidiaries, owns and invests in real estate serving the healthcare industry. The Company's primary business consists of acquiring, financing and owning real estate property to be leased to third-party tenants in the healthcare sector. The Company invests primarily in the United States nursing home industry, including skilled nursing and transitional care facilities, the United States and Canadian senior housing industry, which includes independent living, assisted living, memory care and continuing care retirement communities, select behavioral health and addiction treatment centers, and acute care and other hospitals. Its skilled nursing facilities provide services that include daily nursing, therapeutic rehabilitation, social services, activities, housekeeping, nutrition, medication management and administrative services for individuals.

AI 分析 of Sabra Health Care REIT Inc (SBRA)

持有

Sabra Health Care REIT Inc is currently a hold. The stock is trading at $18.96, which is below the analyst price targets of $21 to $25, suggesting potential upside. However, the RSI is at 31.401, indicating it is oversold, and the recent net loss of $0.10 per share in Q2 2026 raises concerns about profitability. The forward P/E ratio of 32.1543 suggests the stock may be overvalued relative to its earnings potential, which is a risk for long-term investors.

分析師評級(12)

上檔空間 +7.98%
持有
4 買進
7 持有
1 賣出
目前: 19.29
最低
20.00
平均
20.83
最高
22.00

Huntington

2026-09-10

目標價

$23

優於大盤

Mizuho

2026-08-31

目標價

$21

中性

Barclays

2026-08-31

目標價

$23

Equal Weight

Raymond James

2026-08-06

目標價

—

Market Perform

Deutsche Bank

2026-07-22

目標價

$25

買進

估值指標

Sabra Health Care REIT Inc(SBRA)目前預期本益比為 32.15,5 年平均預期本益比為 31.73。

預期本益比

合理
5 年均值 P/E
31.73
目前P/E
32.15
高估
54.04
低估
9.41

預期 EV/EBITDA

嚴重高估
5 年均值 EV/EBITDA
16.46
目前EV/EBITDA
88.80
高估
31.41
低估
1.51

預期股價營收比

合理
5 年均值 P/S
5.09
目前P/S
4.83
高估
5.64
低估
4.53

Alphio AI 對 SBRA 的價格情境

情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

樂

樂觀

樂觀 · 25%SBRA

$19.80

情境價格

基

基準

基準 · 50%SBRA

$16.16

情境價格

悲

悲觀

悲觀 · 25%SBRA

$13.50

情境價格

持有 SBRA 的大戶

C

CenterSquare Investment Management LLC

+ 持有SBRA

-9.13%

3個月報酬率

SBRA 常見問題 —— 由 Alphio AI 解答

Sabra Health Care REIT Inc operates as a self-administered, self-managed real estate investment trust that, through its subsidiaries, owns and invests in real estate serving the healthcare industry. The Company's primary business consists of acquiring, financing and owning real estate property to be leased to third-party tenants in the healthcare sector. The Company invests primarily in the United States nursing home industry, including skilled nursing and transitional care facilities, the United States and Canadian senior housing industry, which includes independent living, assisted living, memory care and continuing care retirement communities, select behavioral health and addiction treatment centers, and acute care and other hospitals. Its skilled nursing facilities provide services that include daily nursing, therapeutic rehabilitation, social services, activities, housekeeping, nutrition, medication management and administrative services for individuals. It operates in the Real Estate sector (REAL ESTATE INVESTMENT TRUSTS industry).

Sabra Health Care REIT Inc is currently a hold. The stock is trading at $18.96, which is below the analyst price targets of $21 to $25, suggesting potential upside. However, the RSI is at 31.401, indicating it is oversold, and the recent net loss of $0.10 per share in Q2 2026 raises concerns about profitability. The forward P/E ratio of 32.1543 suggests the stock may be overvalued relative to its earnings potential, which is a risk for long-term investors.

12 analysts cover SBRA: 4 rate it Buy, 7 Hold and 1 Sell. The average price target is 20.83.

暫無貼文

註冊或登入後參與討論

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易